Breaking
Sunday, June 14, 2026

Clinical Trials

🇺🇸 FDA Page 18

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.

Showing 205–216 of 380 articles

Standard impact AnalysisMay 2, 2026

African Medicines Agency impact: Harmonizing Clinical Trials in Africa

African Medicines Agency (AMA) · HIV · 9 min

Arjun Menon
Standard impact AnalysisMay 2, 2026

ANVISA Clinical Trial Regulations: What Foreign Pharma Must Know in 2025

ANVISA · General Clinical Trials · 12 min

Dr. Priya Nandakumar
Standard impact AnalysisMay 2, 2026

Decentralized Clinical Trials in LATAM: Growth, Challenges & Regulatory Insights

ANVISA, COFEPRIS · Clinical Trials · 9 min

Dr. Yuna Park
High impact AnalysisMay 2, 2026

HIV Treatment Clinical Trials Africa: Long-Acting Injectables & AMA Pathways

African Medicines Agency · HIV/AIDS · 8 min

Dr. Grace Tan
Critical impact NewsMay 2, 2026

Neurocrine Biosciences CRENESSITY Shows Sustained Benefits in Two-Year Pediatric CAH Study

2 min

Dr. Priya Nandakumar
High impact NewsMay 2, 2026

Cairn Surgical's Breast Cancer Locator System Meets Primary Endpoint in Pivotal Trial, Reduces Positive Margin Rates

2 min

James Chen, PharmD
High impact NewsMay 2, 2026

Oculis to Present DME Research and Pipeline Updates at ARVO 2026 Annual Meeting

2 min

Daniel Brooks
High impact NewsMay 2, 2026

Viatris Presents Six Studies on Low-Dose Estrogen Contraceptive Patch at ACOG 2026

2 min

Daniel Brooks
Critical impact NewsMay 2, 2026

Moderna FDA Talks Focus on Phase 4 COVID Vaccine Data

FDA · COVID-19 · 7 min

Dr. Hannah O'Connor
Critical impact NewsMay 1, 2026

MRM Health's MH002 Receives FDA Fast Track Designation for Ulcerative Colitis Treatment

FDA · 2 min

Dr. Emily Carter
High impact NewsMay 1, 2026

Cadrenal Therapeutics CAD-1005 Gets FDA Guidance for Phase 3 Trial in Heparin-Induced Thrombocytopenia

FDA · Hematology/Thrombotic Disorders · 3 min

Dr. Emily Carter
High impact NewsMay 1, 2026

RedHill's RHB-204 Shows Comparable Efficacy to RHB-104 in Crohn's Disease MAP Treatment Development

2 min

Dr. Priya Nandakumar